Poxvirus vectors

Vaccine

Volumn 31, Issue 39, 2013, Pages 4217-4219

  Kreijtz, Joost H C M ^a   Gilbert, Sarah C ^b   Sutter, Gerd ^c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; POXVIRUS VECTOR; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS VECTOR;

CANCER CELL; CELLULAR IMMUNITY; EDITORIAL; IMMUNIZATION; IMMUNOGENICITY; IMMUNOSTIMULATION; INNATE IMMUNITY; MYXOMA VIRUS; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); POXVIRUS; PRIORITY JOURNAL; PUBLIC-PRIVATE PARTNERSHIP; VIRUS CELL INTERACTION;

ANIMALS; CHORDOPOXVIRINAE; CLINICAL TRIALS AS TOPIC; DRUG DESIGN; DRUG INDUSTRY; GENETIC VECTORS; HUMANS; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 84882866594     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.06.073     Document Type: Editorial

References (0)